Q1 2017

Filed May 15, 2017 · 10-Q · 45 days after period end · 0001213900-17-005202

Q1 2017 · 10-Q

Revenue

$7.44K

−76.4% vs Q1 2016

Net Income

-$64.59K

N/M vs Q1 2016

EPS Diluted

-$0.03

N/M vs Q1 2016

Gross Profit-$6,237N/M

Operating Income

Same quarter

Metric	Q1 2017	Q1 2016	Q1 2015	Q1 2014
Revenue	$7.44K	$31.53K	$62.49K	$208.36K
Net Income	-$64.59K	-$455.04K	-$39.06K	$62.78K
EPS Diluted	-$0.03	-$0.02	-$0.01	$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR